tissue specimen Applications
-
Diagnostic Tests Kit for Bladder Cancer
Bladder cancer is the seventh most common cancer diagnosis in worldwide, with 500 000 new cases and 200 000 deaths in 2018 (Globocan 2018). More than 2.7 million people have a history of bladder cancer worldwide. At the initial diagnosis of bladder cancer, more than 80% of cases are diagnosed as non-muscle-invasive bladder cancer (NMIBC). Due to the very high recurrence rate (>80%), NMIBC patients require lifelong surveillance with periodic follow-up cystoscopy (an unpleasant invasive exam) and urine cytology ...
By OncoDiag based in Miserey, FRANCE.
-
Fluorescence Imaging Solutions for Clinical Trials
Pegloprastide (also known as AVB-620) has completed a Phase 2 registration trial for fluorescent detection of cancer during breast cancer surgery (NCT03113825), as well as a Phase 1b clinical trial in women undergoing breast cancer surgery ...
By Avelas Biosciences based in La Jolla, CALIFORNIA (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you